Wegovy Maker Novo Nordisk Forecasts Sales Decline in 2026
Novo Nordisk(US:NVO) WSJ·2026-02-03 17:18The Danish drugmaker said adjusted sales should decline between 5% and 13% at constant exchange rates in 2026, a reversal from last year, when sales grew 10%. ...